115 related articles for article (PubMed ID: 7702225)
21. Universal HIV screening of pregnant women in England: cost effectiveness analysis.
Postma MJ; Beck EJ; Mandalia S; Sherr L; Walters MD; Houweling H; Jager JC
BMJ; 1999 Jun; 318(7199):1656-60. PubMed ID: 10373167
[TBL] [Abstract][Full Text] [Related]
22. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania.
Sweat M; Gregorich S; Sangiwa G; Furlonge C; Balmer D; Kamenga C; Grinstead O; Coates T
Lancet; 2000 Jul; 356(9224):113-21. PubMed ID: 10963247
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
Pinkerton SD; Holtgrave DR; Pinkerton HJ
Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
[TBL] [Abstract][Full Text] [Related]
26. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials.
Parsonnet J; Harris RA; Hack HM; Owens DK
Lancet; 1996 Jul; 348(9021):150-4. PubMed ID: 8684154
[TBL] [Abstract][Full Text] [Related]
27. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.
Mauskopf JA; Paul JE; Wichman DS; White AD; Tilson HH
JAMA; 1996 Jul; 276(2):132-8. PubMed ID: 8656505
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
[TBL] [Abstract][Full Text] [Related]
29. Systematic review on the cost-effectiveness of public health interventions for HIV prevention in industrialized countries.
Schrappe M; Lauterbach K
AIDS; 1998; 12 Suppl A():S231-8. PubMed ID: 9633007
[TBL] [Abstract][Full Text] [Related]
30. The cost-effectiveness of human immunodeficiency virus screening in pregnancy.
Ecker JL
Am J Obstet Gynecol; 1996 Feb; 174(2):716-21. PubMed ID: 8623812
[TBL] [Abstract][Full Text] [Related]
31. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
[TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood.
AuBuchon JP; Birkmeyer JD; Busch MP
Transfusion; 1997 Jan; 37(1):45-51. PubMed ID: 9024489
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of environmental-structural communication interventions for HIV prevention in the female sex industry in the Dominican Republic.
Sweat M; Kerrigan D; Moreno L; Rosario S; Gomez B; Jerez H; Weiss E; Barrington C
J Health Commun; 2006; 11 Suppl 2():123-42. PubMed ID: 17148102
[TBL] [Abstract][Full Text] [Related]
34. The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection.
Lurie P; Avins AL; Phillips KA; Kahn JG; Lowe RA; Ciccarone D
JAMA; 1994 Dec; 272(23):1832-8. PubMed ID: 7990217
[TBL] [Abstract][Full Text] [Related]
35. The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care.
Grobman WA; Garcia PM
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1062-71. PubMed ID: 10561619
[TBL] [Abstract][Full Text] [Related]
36. [Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries].
Gentilini M; Chieze F
Bull Acad Natl Med; 1990 Nov; 174(8):1209-19; discussion 1219-21. PubMed ID: 2094555
[TBL] [Abstract][Full Text] [Related]
37. From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand.
Thaineua V; Sirinirund P; Tanbanjong A; Lallemant M; Soucat A; Lamboray JL
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):429-42. PubMed ID: 10437936
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of HIV post-exposure prophylaxis in France.
Herida M; Larsen C; Lot F; Laporte A; Desenclos JC; Hamers FF
AIDS; 2006 Aug; 20(13):1753-61. PubMed ID: 16931940
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis.
Baggaley RF; Irvine MA; Leber W; Cambiano V; Figueroa J; McMullen H; Anderson J; Santos AC; Terris-Prestholt F; Miners A; Hollingsworth TD; Griffiths CJ
Lancet HIV; 2017 Oct; 4(10):e465-e474. PubMed ID: 28768604
[TBL] [Abstract][Full Text] [Related]
40. Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa.
Larson BA; Rockers PC; Bonawitz R; Sriruttan C; Glencross DK; Cassim N; Coetzee LM; Greene GS; Chiller TM; Vallabhaneni S; Long L; van Rensburg C; Govender NP
PLoS One; 2016; 11(7):e0158986. PubMed ID: 27390864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
